Cargando…
Targeting androgen receptor-independent pathways in therapy-resistant prostate cancer
Since androgen receptor (AR) signaling is critically required for the development of prostate cancer (PCa), targeting AR axis has been the standard treatment of choice for advanced and metastatic PCa. Unfortunately, although the tumor initially responds to the therapy, treatment resistance eventuall...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Second Military Medical University
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363598/ https://www.ncbi.nlm.nih.gov/pubmed/30775252 http://dx.doi.org/10.1016/j.ajur.2018.11.002 |